Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Recent Patents on Anti-Infective Drug Discovery|January 29, 2008
Recent advances in malaria drug discoveryCharlotte A Lanteri, Jacob D Johnson, Norman C Waters
Journal of Leukocyte Biology|September 10, 2003
CD44, alpha(4) integrin, and fucoidin receptor-mediated phagocytosis of apoptotic leukocytesJacob D Johnson, Krista L Hess, Joan M Cook-Mills
The American Journal of Tropical Medicine and Hygiene|December 7, 2011
Inhibitory activity of ferroquine, versus chloroquine, against western Kenya Plasmodium falciparum field isolates determined by a SYBR Green I in vitro assayFredrick L Eyase, Hoseah M Akala, Jacob D Johnson, et al.
Investigational New Drugs|March 31, 2010
A novel activity from an old compound: Manzamine A reduces the metastatic potential of AsPC-1 pancreatic cancer cells and sensitizes them to TRAIL-induced apoptosisEsther A Guzmán, Jacob D Johnson, Patricia A Linley, et al.
Antimicrobial Agents and Chemotherapy|April 8, 2009
Assessment of malaria in vitro drug combination screening and mixed-strain infections using the malaria Sybr green I-based fluorescence assayEdgie-Mark A Co, Richard A Dennull, Drew D Reinbold, et al.
The Biochemical Journal|November 5, 2003
Calcium mobilization and Rac1 activation are required for VCAM-1 (vascular cell adhesion molecule-1) stimulation of NADPH oxidase activityJoan M Cook-Mills, Jacob D Johnson, Tracy L Deem, et al.
Applied and Environmental Microbiology|April 27, 2010
Lactococcus lactis fabH, encoding beta-ketoacyl-acyl carrier protein synthase, can be functionally replaced by the Plasmodium falciparum congenerYu Du, Jolyn E Gisselberg, Jacob D Johnson, et al.
Antimicrobial Agents and Chemotherapy|March 21, 2007
Assessment and continued validation of the malaria SYBR green I-based fluorescence assay for use in malaria drug screeningJacob D Johnson, Richard A Dennull, Lucia Gerena, et al.
American Journal of Rhinology & Allergy|August 3, 2026
Revision Endoscopic Sinus Surgery in Cystic Fibrosis With Chronic Rhinosinusitis: Before and After Cystic Fibrosis Transmembrane Conductance Regulator Triple Modulator TherapyBrian P Kinealy, Anthony A Mangino, Jacob D Johnson, et al.
Molecular and Biochemical Parasitology|January 22, 2011
Design of anti-parasitic and anti-fungal hydroxy-naphthoquinones that are less susceptible to drug resistanceLouise M Hughes, Charlotte A Lanteri, Michael T O'Neil, et al.
Pageof 3